197 related articles for article (PubMed ID: 34424228)
1. Bioluminescent Optogenetics 2.0: Harnessing Bioluminescence to Activate Photosensory Proteins In Vitro and In Vivo.
Crespo EL; Bjorefeldt A; Prakash M; Hochgeschwender U
J Vis Exp; 2021 Aug; (174):. PubMed ID: 34424228
[TBL] [Abstract][Full Text] [Related]
2. Bioluminescent optogenetic (BL-OG) activation of neurons during mouse postnatal brain development.
Crespo EL; Prakash M; Bjorefeldt A; Medendorp WE; Shaner NC; Lipscombe D; Moore CI; Hochgeschwender U
STAR Protoc; 2021 Sep; 2(3):100667. PubMed ID: 34286295
[TBL] [Abstract][Full Text] [Related]
3. Bioluminescence-Optogenetics: A Practical Guide.
Stern MA; Skelton H; Fernandez AM; Gutekunst CN; Berglund K; Gross RE
Methods Mol Biol; 2022; 2525():333-346. PubMed ID: 35836081
[TBL] [Abstract][Full Text] [Related]
4. The BioLuminescent-OptoGenetic in vivo response to coelenterazine is proportional, sensitive, and specific in neocortex.
Gomez-Ramirez M; More AI; Friedman NG; Hochgeschwender U; Moore CI
J Neurosci Res; 2020 Mar; 98(3):471-480. PubMed ID: 31544973
[TBL] [Abstract][Full Text] [Related]
5. Defining parameters of specificity for bioluminescent optogenetic activation of neurons using in vitro multi electrode arrays (MEA).
Prakash M; Medendorp WE; Hochgeschwender U
J Neurosci Res; 2020 Mar; 98(3):437-447. PubMed ID: 30152529
[TBL] [Abstract][Full Text] [Related]
6. Coelenterazine-Type Bioluminescence-Induced Optical Probes for Sensing and Controlling Biological Processes.
Jiang T; Song J; Zhang Y
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982148
[TBL] [Abstract][Full Text] [Related]
7. Applications of Bioluminescence-Optogenetics in Rodent Models.
Stern MA; Skelton H; Fernandez AM; Gutekunst CN; Gross RE; Berglund K
Methods Mol Biol; 2022; 2525():347-363. PubMed ID: 35836082
[TBL] [Abstract][Full Text] [Related]
8. Improved Locomotor Recovery in a Rat Model of Spinal Cord Injury by BioLuminescent-OptoGenetic (BL-OG) Stimulation with an Enhanced Luminopsin.
Ikefuama EC; Kendziorski GE; Anderson K; Shafau L; Prakash M; Hochgeschwender U; Petersen ED
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361784
[TBL] [Abstract][Full Text] [Related]
9. Seeing (and Using) the Light: Recent Developments in Bioluminescence Technology.
Love AC; Prescher JA
Cell Chem Biol; 2020 Aug; 27(8):904-920. PubMed ID: 32795417
[TBL] [Abstract][Full Text] [Related]
10. Bioluminescence-Optogenetics.
Berglund K; Stern MA; Gross RE
Adv Exp Med Biol; 2021; 1293():281-293. PubMed ID: 33398820
[TBL] [Abstract][Full Text] [Related]
11. Building Biological Flashlights: Orthogonal Luciferases and Luciferins for
Williams SJ; Prescher JA
Acc Chem Res; 2019 Nov; 52(11):3039-3050. PubMed ID: 31593431
[TBL] [Abstract][Full Text] [Related]
12. Combined Optogenetic and Chemogenetic Control of Neurons.
Berglund K; Tung JK; Higashikubo B; Gross RE; Moore CI; Hochgeschwender U
Methods Mol Biol; 2016; 1408():207-25. PubMed ID: 26965125
[TBL] [Abstract][Full Text] [Related]
13. Step-function luminopsins for bimodal prolonged neuromodulation.
Berglund K; Fernandez AM; Gutekunst CN; Hochgeschwender U; Gross RE
J Neurosci Res; 2020 Mar; 98(3):422-436. PubMed ID: 30957296
[TBL] [Abstract][Full Text] [Related]
14. Efficient opto- and chemogenetic control in a single molecule driven by FRET-modified bioluminescence.
Björefeldt A; Murphy J; Crespo EL; Lambert GG; Prakash M; Ikefuama EC; Friedman N; Brown TM; Lipscombe D; Moore CI; Hochgeschwender U; Shaner NC
Neurophotonics; 2024 Apr; 11(2):021005. PubMed ID: 38450294
[TBL] [Abstract][Full Text] [Related]
15. Light-emitting channelrhodopsins for combined optogenetic and chemical-genetic control of neurons.
Berglund K; Birkner E; Augustine GJ; Hochgeschwender U
PLoS One; 2013; 8(3):e59759. PubMed ID: 23544095
[TBL] [Abstract][Full Text] [Related]
16. Bioluminescence imaging in mice with synthetic luciferin analogues.
Ji X; Adams ST; Miller SC
Methods Enzymol; 2020; 640():165-183. PubMed ID: 32560797
[TBL] [Abstract][Full Text] [Related]
17. Non-invasive activation of optogenetic actuators.
Birkner E; Berglund K; Klein ME; Augustine GJ; Hochgeschwender U
Proc SPIE Int Soc Opt Eng; 2014 Feb; 8928():. PubMed ID: 27965518
[TBL] [Abstract][Full Text] [Related]
18. Luminopsins integrate opto- and chemogenetics by using physical and biological light sources for opsin activation.
Berglund K; Clissold K; Li HE; Wen L; Park SY; Gleixner J; Klein ME; Lu D; Barter JW; Rossi MA; Augustine GJ; Yin HH; Hochgeschwender U
Proc Natl Acad Sci U S A; 2016 Jan; 113(3):E358-67. PubMed ID: 26733686
[TBL] [Abstract][Full Text] [Related]
19. A New Highly Efficient Molecule for Both Optogenetic and Chemogenetic Control Driven by FRET Amplification of BioLuminescence.
Bjorefeldt A; Murphy J; Crespo EL; Lambert GG; Prakash M; Ikefuama EC; Friedman N; Brown TM; Lipscombe D; Moore CI; Hochgeschwender U; Shaner NC
bioRxiv; 2023 Dec; ():. PubMed ID: 37425735
[TBL] [Abstract][Full Text] [Related]
20. Bioluminescent Optogenetics: A Novel Experimental Therapy to Promote Axon Regeneration after Peripheral Nerve Injury.
English AW; Berglund K; Carrasco D; Goebel K; Gross RE; Isaacson R; Mistretta OC; Wynans C
Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
